Stuart B M, Gent A E
Department of Medicine, Salisbury District Hospital, Wilts, UK.
Eur J Gastroenterol Hepatol. 1998 Jun;10(6):523-5. doi: 10.1097/00042737-199806000-00016.
Details of 12 patients suffering from atrophy of the coeliac mucosa (ACM) are presented. These patients failed to respond to the elimination of gluten from their diets. Their jejunal biopsies were examined in detail with particular attention given to Paneth cell numbers, crypt length, mitotic rate and mucosal thickness. These biopsies were compared with the biopsies of responsive coeliac patients. The ACM patients were found to have a statistically significant reduction in Paneth cell numbers (P < 0.0005), reduced crypt length (P < 0.0125), reduced mitotic rate (P < 0.0005) and a thinner mucosa (P < 0.0005), when compared with the responsive coeliac group. In addition the ACM group had a lower albumin level compared with the responsive group (P < 0.0005). Most of the ACM patients responded when treated with oral corticosteroids. It is considered that the above features are markers of a non-responsive group of coeliac patients and thus might be useful for identifying those patients who may benefit from early treatment with oral corticosteroids if gluten withdrawal is not rapidly effective.
本文介绍了12例患有腹腔黏膜萎缩(ACM)患者的详细情况。这些患者在饮食中去除麸质后并无反应。对他们的空肠活检组织进行了详细检查,特别关注了潘氏细胞数量、隐窝长度、有丝分裂率和黏膜厚度。将这些活检组织与有反应的腹腔疾病患者的活检组织进行了比较。结果发现,与有反应的腹腔疾病组相比,ACM患者的潘氏细胞数量在统计学上显著减少(P < 0.0005),隐窝长度缩短(P < 0.0125),有丝分裂率降低(P < 0.0005),黏膜更薄(P < 0.0005)。此外,ACM组的白蛋白水平低于有反应的组(P < 0.0005)。大多数ACM患者在接受口服皮质类固醇治疗时有反应。据认为,上述特征是腹腔疾病无反应患者组的标志物,因此可能有助于识别那些如果停用麸质后不能迅速起效,可能从早期口服皮质类固醇治疗中获益的患者。